Total Knee Arthroplasty - Accelerated Recovery Without Tourniquet
1 other identifier
interventional
70
1 country
1
Brief Summary
Introduction: Approximately 7000 total knee replacements (TKAs) are done every year. More than 90% of these knee replacements are performed with the use of bone cement. Traditionally, a tourniquet has been, used to reduce the bleeding during surgery, enabling surgeons to perform delicate dissections in a bloodless operative field. A tourniquet can be defined as a constricting or compressing device used to control temporarily venous and arterial circulation to an extremity. Pressure is applied circumferentially on the skin and underlying tissues of a limb. This pressure is transferred to the walls of vessels, causing them to become occluded. It is well known that applying a tourniquet for more than 1 to 2 hours is associated with a number of disadvantages, for instance, severe pain and muscle effects during the first postoperative day, thereby slowing rehabilitation. Other side effects related to tourniquet use, include pulmonary embolus caused by venous thrombosis and arterial thrombosis as a result of the dislodgement of an arterial plaque. Furthermore, tourniquet-induced hypertension with general anaesthesia, muscle injury, a wide spectrum of neurologic injuries, and tissue changes (Oedema compartment syndrome, post-tourniquet syndrome) have been reported. An important fact is that bleeding affects the quality of binding between bone and cement and thereby fixation of the knee prosthesis? Since the introduction of modern cementing techniques, no previous clinical studies have investigated the advantages or disadvantages of tourniquet use in knee replacement surgery. Aims/hypothesis of the study:
- 1.To investigate the advantages and disadvantages of tourniquet use, including whether not using a tourniquet reduces pain, facilitates mobilisation and recovery, and shortens length of stay.
- 2.To study whether use of a tourniquet affects leg muscles during and after surgery, as measured by with use of microdialysis to quantify level of ischemia .
- 3.To determine whether prosthesis fixation, measured by RSA, is affected by tourniquet use. Because third generation cements secure prosthesis fixation, the investigators do not expect to find any clinically significant migration (less than 2 mm) 2 years after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2011
CompletedStudy Start
First participant enrolled
March 1, 2011
CompletedFirst Posted
Study publicly available on registry
March 4, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedJanuary 30, 2015
January 1, 2015
3.2 years
January 14, 2011
January 29, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Determine whether prosthesis fixation, measured by RSA, is affected by tourniquet use.
To determine whether prosthesis fixation, measured by RSA, is affected by tourniquet use. Because third generation cements secure prosthesis fixation, we do not expect to find any clinically significant migration (less than 2 mm) 2 years after surgery.
1.Feb 2011 -1 jan 2013
Secondary Outcomes (1)
To investigate the advantages and disadvantages of tourniquet use, including whether not using a tourniquet reduces pain, facilitates mobilisation and recovery, and shortens length of stay.
1.feb 2011 - 1.jan 2013
Study Arms (2)
With Tourniquet
ACTIVE COMPARATORTotal Knee Arthroplasty. Surgery performed during use of a tourniquet.
Without Tourniquet
EXPERIMENTALTotal Knee Arthroplasty. Surgery performed without use of a tourniquet.
Interventions
Eligibility Criteria
You may qualify if:
- Patients with symptomatic and radiographic verified knee symptoms, selected for primary unilateral total knee joint replacement (TKR)
- Age 50 and above (not older than 85)
- BMI \< 35 and height \>160 cm
- No severe cardiovascular conditions
- No previously knee surgery done in the same knee
- Oral and written acceptance
You may not qualify if:
- Severe obesity
- rheumatic diseases
- Absence of pulse in foot
- Diabetes
- Previous operation in concerning knee
- Lack of informed consent or ability to read / understand Danish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aalborg University Hospital, Northern Orthopaedic Division, Department of Arthroplasty, Farsoe Clinic
Farsø, Northern Jutland, Denmark
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2011
First Posted
March 4, 2011
Study Start
March 1, 2011
Primary Completion
May 1, 2014
Study Completion
May 1, 2014
Last Updated
January 30, 2015
Record last verified: 2015-01